2022
DOI: 10.1016/j.bjane.2022.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Non-reactive mydriasis after rocuronium infusion in patients with COVID-19: a case series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
6
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 9 publications
(26 reference statements)
0
6
0
Order By: Relevance
“…Non-depolarizing neuromuscular agents (NMBAs) do not regularly cross the Blood-Brain Barrier (BBB) because of their considerable molecular weight and low liposolubility; however, there are cases in the literature to support particular circumstances that facilitate their cross over the CNS and developing clinical manifestations. 2,3…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Non-depolarizing neuromuscular agents (NMBAs) do not regularly cross the Blood-Brain Barrier (BBB) because of their considerable molecular weight and low liposolubility; however, there are cases in the literature to support particular circumstances that facilitate their cross over the CNS and developing clinical manifestations. 2,3…”
Section: Discussionmentioning
confidence: 99%
“…Fernadez et al 2 reported three cases that manifested mydriasis attributed to rocuronium infusion in COVID-19 patients, which was withdrawn after the NMBA infusion stopped. At least one of them had a concurrent bacterial infection.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…(Non-reactive) mydriasis after rocuronium infusion has been reported in literature 15–18. However, this encompasses cases with continuous infusion for a prolonged time.…”
Section: Discussionmentioning
confidence: 99%
“…3 (Non-reactive) mydriasis after rocuronium infusion has been reported in literature. [15][16][17][18] However, this encompasses cases with continuous infusion for a prolonged time. In these studies, mydriasis was observed within a range of 8-156 hours after start of continuous infusion.…”
Section: Discussionmentioning
confidence: 99%